SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 8th, 2020 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 7, 2020, between Zomedica Pharmaceuticals Corp., an Alberta corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 8th, 2020 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • New York
PLACEMENT AGENT COMMON SHARE PURCHASE WARRANT Zomedica Pharmaceuticals Corp.Zomedica Pharmaceuticals Corp. • April 8th, 2020 • Pharmaceutical preparations
THIS PLACEMENT AGENT COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April __, 2025 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Zomedica Pharmaceuticals Corp., an Alberta corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common shares (the “Common Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of March 31, 2020, by and between the Company and H.C. Wainwright & Co., LLC.
